When Should Bone Marrow Transplantation be Considered in Primary Immunodeficiency?
Saturday, March 1, 2014: 12:30 PM-1:30 PM
Marriott South Tower, Level 3, Balboa
1.00 CME/ 1.20 CE
Primary Discussion Leaders:
Rebecca A. Marsh , MD
Elena E. Perez , MD PhD FAAAAI
Learning Objectives:
  1. Review the primary immunodeficiency diseases for which BMT can be a curative treatment
  2. Discuss how soon after diagnosis a patient with certain immunodeficiency disorders should be referred to a BMT center
  3. Review any therapies to be avoided prior to a patient going to transplant
  • Hematopoietic Cell Transplantation for Primary Immune Deficiencies AAAAI Handout 2013-1.pdf (87.3 kB)
  • See more of: Seminar